ED
AET

Exane Derivatives’s Aetna Inc AET Stock Holding History

Exane Derivatives’s Portfolio AET Stock Details AET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed -$124 – 705
2016
Q4 		$124 Sell
1
-77
-99% -$9.22K ﹤0.01% 530
2016
Q3 		$9K Sell
78
-144
-65% -$16.9K ﹤0.01% 410
2016
Q2 		$27.1K Sell
222
-61
-22% -$7K ﹤0.01% 313
2016
Q1 		$31.8K Hold
283
– – ﹤0.01% 358
2015
Q4 		$30.6K Buy
283
+158
+126% +$17.1K ﹤0.01% 275
2015
Q3 		$13.7K Sell
125
-197,575
-100% -$22.8M ﹤0.01% 332
2015
Q2 		$25.2M Buy
197,700
+196,329
+14,320% +$22.4M 2.71% 2
2015
Q1 		$146K Sell
1,371
-2,788
-67% -$273K 0.02% 238
2014
Q4 		$369K Buy
+4,159
New +$349K 0.05% 162

Other funds holding AET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Exane Derivatives's AET Position: Q1 2017 in Review

Exane Derivatives sold out of Aetna Inc (AET) in Q1 2017, closing a stake of 1 share — an estimated $124 sold.

Exane Derivatives first reported a position in AET in Q4 2014 and held it in 9 quarters. The position peaked at $25.2M in Q2 2015. 880 funds tracked by Wall St. Rank hold AET as of Q1 2017.

  • Exane Derivatives reported no remaining Aetna Inc position as of Q1 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 Aetna Inc share in Q1 2017, an estimated $124.
  • Exane Derivatives first reported a position in Aetna Inc in Q4 2014 and held it in 9 quarters.
  • Exane Derivatives's Aetna Inc position peaked at $25.2M in Q2 2015.
  • 880 funds tracked by Wall St. Rank held Aetna Inc as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.